Alternatives to death: Understanding androgen-independent prostate cancer

被引：0
|
作者：
Joel B. Nelson
机构：
[1] Brady Urological Institute Johns Hopkins Medical Institutions ,
来源：
Nature Medicine | 1998年 / 4卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Decreased levels of caveolin promote sensitivity to androgen withdrawal in prostate cancer cells, suggesting another therapeutic target for the treatment of prostate cancer (pages 1062–1064).
引用
收藏
页码：1011 / 1012
页数：1
相关论文
共 50 条
  • [41] Imatinib mesylate and zoledronic acid in androgen-independent prostate cancer
    Altundag, K
    Altundag, O
    Morandi, P
    Gunduz, M
    UROLOGY, 2005, 65 (01) : 211 - 212
  • [42] The potential for neurocognitive toxicity in the treatment of androgen-independent prostate cancer
    Garofalo, J.
    Heinige-Kenworthy, T.
    Beer, T.
    PSYCHO-ONCOLOGY, 2007, 16 (03) : S70 - S70
  • [43] Thalidomide/estramustme/pacfitaxel in metastatic androgen-independent prostate cancer
    Mathew, Paul
    Logothetis, Christopher J.
    Dieringer, Pauline Y.
    Chen, Isan
    Pagliaro, Lance C.
    Bekele, Benjamin N.
    Zhou, Man
    Daliani, Danai D.
    CLINICAL GENITOURINARY CANCER, 2006, 5 (02) : 144 - 149
  • [44] Molecular biology of androgen-independent prostate cancer: the role of the androgen receptor pathway
    Mellado, Begona
    Codony, Jordi
    Ribal, Maria Jose
    Visa, Laura
    Gascon, Pere
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2009, 11 (01): : 5 - 10
  • [45] Functional characterization of mutant androgen receptors from androgen-independent prostate cancer
    Fenton, MA
    Shuster, TD
    Fertig, AM
    Taplin, ME
    Kolvenbag, G
    Bubley, GJ
    Balk, SP
    CLINICAL CANCER RESEARCH, 1997, 3 (08) : 1383 - 1388
  • [46] Targeting androgen-independent prostate cancer through epigenetic reprogramming
    Puca, Loredana
    Gao, Dong
    Kossai, Myriam
    Cyrta, Joanna
    Marotz, Clarisse
    Mosquera, Juan Miguel
    MacDonald, Theresa Y.
    Sboner, Andrea
    Rao, Rema
    Chen, Yu
    Rubin, Mark A.
    Beltran, Himisha
    CANCER RESEARCH, 2016, 76
  • [47] Lef1 Expression in Androgen-Independent Prostate Cancer
    Zhang, M.
    Li, Y. R.
    Wang, L. G.
    Melamed, J.
    Liu, X. M.
    Wei, J. J.
    Peng, Y.
    Pellicer, A.
    Garabedian, M. J.
    Ferrari, A.
    Lee, P.
    MODERN PATHOLOGY, 2009, 22 : 203A - 203A
  • [48] Novel therapeutic strategies for androgen-independent prostate cancer: An update
    Assikis, VJ
    Simons, JW
    SEMINARS IN ONCOLOGY, 2004, 31 (02) : 26 - 32
  • [49] Acid phosphatase: Defining a role in androgen-independent prostate cancer
    Steineck, G
    Kelly, WK
    Mazumdar, M
    Vlamis, V
    Schwartz, M
    Scher, HI
    UROLOGY, 1996, 47 (05) : 719 - 726
  • [50] High molecular mass proteome of androgen-independent prostate cancer
    Kuruma, H
    Egawa, S
    Oh-Ishi, M
    Kodera, Y
    Satoh, M
    Chen, WG
    Okusa, H
    Matsumoto, K
    Maeda, T
    Baba, S
    PROTEOMICS, 2005, 5 (04) : 1097 - 1112
12345